Clinical Trials Browser

Advanced Solid Malignancies

Carcinoma, Non-Small-Cell Lung

Liver Cirrhosis

Advanced Pancreatic Cancer

Pancreatic Neoplasms

Colorectal Neoplasms

Prostatic Neoplasms

Neoplasm Metastasis

Healthy Participants

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Advanced Solid Tumor

Pancreatic Neoplasms

Thyroid Cancer, Papillary, Thyroid Neoplasms

Breast Neoplasms, Neoplastic Cells, Circulating

Healthy Participants

Advanced Solid Tumor

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

cMET-dysregulated Advanced Solid Tumors

Drug-drug Interaction,SHR3680

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Breast Neoplasms

Head and Neck Neoplasms

Melanoma, Neoplasms

Clinical Trials

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

MK-1084-009

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors

FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer

Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer

Digoxin for Recurrent Prostate Cancer

A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors

A Clinical Trial to Investigate the Clinical Drug-Drug Interaction of Divarasib With Probe Substrates of P-Glycoprotein and Breast Cancer Resistance Protein in Healthy Participants

Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cancer (WU-KONG19)

A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin

A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates

C3

DIGUP-TC

Digoxin Induced Dissolution of CTC Clusters

A Study to Assess the Effect of AZD5462 on the Pharmacokinetics of Midazolam, Rosuvastatin and Digoxin

A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advanced Solid Tumor Subjects

Safety and Activity of Digoxin With Decitabine in Adult AML and MDS

A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer

Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.

Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects

A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma

A Clinical Trial of Patients With Melanoma

Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer

Capecitabine With Digoxin for Metastatic Breast Cancer

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

DIGHANC

A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma